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Abstract
There is considerable interest in the ex vivo propagation of primary human basal epithelial
stem/progenitor cells with a view to their use in drug development, toxicity testing and regen-
erative medicine. These cells can be expanded in co-culture with mitotically inactivated 3T3-
J2 murine embryonic feeder cells but, similar to other epithelial cell culture systems employ-
ing 3T3-J2 cells, the aspects of cross-talk between 3T3-J2 cells and human airway basal
cells that are critical for their expansion remain largely unknown. In this study, we investi-
gated secreted growth factors that are produced by 3T3-J2 cells and act upon primary
human airway basal cells. We found robust production of hepatocyte growth factor (HGF)
from fibroblast feeder cells following mitotic inactivation. Consistent with the limited cross-
species reactivity of murine HGF on the human HGF receptor (MET; HGFR), MET inhibition
did not affect proliferative responses in human airway basal cells and HGF could not replace
feeder cells in this culture system. However, we found that murine HGF is not completely
inactive on human airway epithelial cells or cancer cell lines but stimulates the phosphoryla-
tion of GRB2-associated-binding protein 2 (GAB2) and signal transducer and activator of
transcription 6 (STAT6). Although HGF induces phosphorylation of STAT6 tyrosine 641
(Y641), there is no subsequent STAT6 nuclear translocation or STAT6-driven transcrip-
tional response. Overall, these findings highlight the relevance of cross-species protein
interactions between murine feeder cells and human epithelial cells in 3T3-J2 co-culture
and demonstrate that STAT6 phosphorylation occurs in response to MET activation in epi-
thelial cells. However, STAT6 nuclear translocation does not occur in response to HGF, pre-
cluding the transcriptional activity of STAT6.
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Introduction
The murine trachea and proximal human airways are lined by a pseudostratified epithelium
consisting of basal epithelial stem/progenitor cells and differentiated mucosecretory and mul-
ticiliated cells [1–3]. Human airway epithelial cells can be expanded in vitro for a limited num-
ber of population doublings using serum-free bronchial epithelial growth medium (BEGM)
[4]. We and others have shown that a technique first used to expand primary epidermal kerati-
nocyte cell culture improves the longevity of airway basal cell cultures and allows prolonged
retention of airway epithelial differentiation capacity in culture [5–7]. In this culture system,
epithelial cells are co-cultured with 3T3-J2 mouse embryonic feeder cells in the presence of a
RHO-associated protein kinase (ROCK) inhibitor, Y-27632 [8–11]. Despite the remarkable
rate of proliferation of primary cells induced by these conditions, basal cells remain karyotypi-
cally stable, express markers typical of adult airway basal stem/progenitor cells and do not
express those characteristic of embryonic or induced pluripotent stem cells [5]. The availability
of a system for extensive expansion of primary human airway epithelial cells offers the oppor-
tunity for more realistic in vitro airway models, higher throughput airway drug and toxicity
testing [12] and may have applications in regenerative medicine [13]. However, despite many
decades of research in which keratinocytes have been co-cultured with 3T3-J2 feeder cells and
the application of these cells in epidermal and corneal cell therapies [14–19], the signalling
processes involved in the cross-talk between these cell types in co-culture are only partially
understood [20].
In this study, we set out to characterise the nature of 3T3-J2 feeder cell cross-talk with
human airway basal cells. Using phospho-receptor tyrosine kinase arrays, we identify murine
hepatocyte growth factor (HGF) as a feeder cell factor capable of phosphorylating the HGF
receptor, MET, on human airway basal epithelial cells. In vivo, HGF is predominantly pro-
duced by immune and stromal cell types and the MET receptor is expressed by epithelial cells,
allowing mesenchymal-epithelial cross-talk. Previous in vitro studies indicate that HGF modu-
lates the survival [21, 22], proliferation [23, 24], motility [25] and differentiation [26, 27] of
lung epithelial cells. However, our result was surprising as mouse HGF is not thought to acti-
vate the human MET receptor [28–30]. Investigation of the downstream effects of HGF-MET
signalling in 3T3-J2-basal cell co-culture confirmed that feeder cell-derived HGF does not
affect human airway basal cell proliferation and so cannot underlie the trophic effects of
3T3-J2 cells in this system. Interestingly, HGF-MET signalling did lead to phosphorylation
of the established MET target GAB2 and a previously undescribed MET target, STAT6, so
murine HGF is not entirely inactive on human airway epithelial cells but rather activates only
a subset of targets downstream of MET. HGF-induced phosphorylated STAT6 is retained in
the cytoplasm and as such does not activate STAT6-dependent transcriptional programmes.
Materials and methods
Cell culture
Ethical approval for the isolation of human airway tracheobronchial epithelial cells from
patient biopsies was obtained through the National Research Ethics Committee (REC refer-
ences 06/Q0505/12 and 11/LO/1522) and patients gave informed, written consent. Primary
human airway basal cells were obtained from adult endobronchial biopsies taken from regions
of healthy airway mucosa and expanded either in bronchial epithelial growth medium
(BEGM; Lonza) or in co-culture with mitotically inactivated 3T3-J2 fibroblast feeder cells in
epithelial cell culture medium containing epidermal growth factor (EGF) and Y-27632 (3T3
+Y) as previously described [5].
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3T3-J2 fibroblast feeder cells were expanded in DMEM (Invitrogen) containing 1X penicil-
lin/streptomycin (Gibco) and 9% bovine serum (Invitrogen). 3T3-J2-conditioned medium
was prepared by inactivating 3T3-J2 fibroblasts with 0.4 μg/ml mitomycin C (Sigma-Aldrich)
for 2 hours and creating feeder layers at a 20,000–30,000 cells/cm2 density [31]. 24 hours after
seeding, fibroblast growth medium was removed and replaced with epithelial cell culture
medium without Y-27632 for 24 hours. This was repeated a maximum of two times; that is,
medium was collected 48 and 72 hours after cell seeding. 48-hour medium was stored at 4˚C
until 72-hour medium was collected and these were combined, filtered using a 0.45 μm filter
and frozen at -80˚C until use. Y-27632 was added immediately before use where indicated.
Antibody arrays
Proteome profiler human phospho-receptor tyrosine kinase (RTK) antibody arrays (R&D Sys-
tems) were performed according to the manufacturer’s instructions. 500 μg fresh protein
lysates were extracted from human airway epithelial cells grown in bronchial epithelial growth
medium (BEGM; Lonza) and treated with media as indicated for 30 minutes. Lysates were
incubated with pre-blocked nitrocellulose membranes overnight at 4˚C on a rocking platform.
Phosphorylated RTKs were detected using Luminata Crescendo HRP substrate (Merck Milli-
pore) and imaged by X-ray film exposure.
Western blotting
Cell lysis was performed using RIPA buffer containing 1X Halt protease and phosphatase
inhibitor cocktail (Thermo Fisher). After scraping, cell lysates were transferred to microfuge
tubes, incubated at 4˚C on a rotating wheel for 30 minutes and centrifuged at 14,000 x g for 10
minutes before supernatants were transferred to a clean microfuge tube. After quantification
by BCA assay, 20 μg protein was denatured by heating at 95˚C for 10 minutes in Laemmli sam-
ple buffer (Sigma-Aldrich), separated on 4–12% Bis-Tris gels (Invitrogen) and transferred
onto nitrocellulose membranes using the iBlot system (Invitrogen). Blots were blocked with
tris-buffered saline containing 0.1% Tween-20 (TBST; Sigma-Aldrich) and 5% skimmed milk
powder (Sigma-Aldrich) for 1 hour at room temperature on a roller mixer. Blots were incu-
bated with primary antibodies [MET: #3135, #3077, #3133 and #8198; GAB2: #3882 and
#3239; STAT6: #9361, #5297 and GTX113273 (GeneTex); α-Tubulin: #9099 (Cell Signaling
Technology unless otherwise stated)] in either TBST containing 5% BSA or TBST containing
5% skimmed milk powder on a roller mixer at 4˚C overnight. After washing a further 3 times
with TBST for 3 minutes, blots were incubated with species-appropriate HRP-conjugated sec-
ondary antibodies (Cell Signaling Technology) for 1 hour at room temperature on a roller
mixer. After washing 3 times with TBST for 3 minutes, blots were developed using Luminata
Crescendo HRP substrate (Merck Millipore) and imaged using an ImageQuant LAS 4000 sys-
tem (GE Healthcare). For re-probing, blots were washed briefly with TBS and incubated with
Restore PLUS western blot stripping buffer (Thermo Fisher) for 15 minutes at room tempera-
ture on a roller mixer.
For experiments involving subcellular fractionation, fractions were isolated using a subcel-
lular protein fractionation kit (Thermo Fisher) according to the manufacturer’s instructions.
Resulting lysates were BCA assayed to normalize protein concentration and western blotted as
described above.
siRNA-mediated knockdown
GAB2 and non-silencing Silencer Select siRNAs were purchased from Life Technologies.
Transfection was performed in primary human airway epithelial cells grown in BEGM
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(Lonza) using Interferin (Polyplus Transfection) according to the manufacturer’s instructions.
Where indicated, cells were stimulated with vehicle control or recombinant human hepatocyte
growth factor (hHGF) for 30 minutes after 72 hours of knockdown and analysed by western
blotting as described above.
Co-immunoprecipitation (IP)
A431 cells were grown in 10 cm dishes until 80% confluence. After overnight serum starvation
in DMEM (Gibco), cells were treated with either a vehicle control, 3 ng/ml hHGF or 50 ng/ml
hHGF (Peprotech) for 30 minutes before lysis in IP Cell Lysis Buffer (Cell Signaling). Protein
concentration was normalised to 2 mg/IP in 1 ml volume and lysates were incubated with
25 μl primary antibody overnight at 4˚C on a rotating wheel. Dynabeads (Protein A; Thermo
Fisher) were used to isolate antibody and bound protein from the lysates according to the
manufacturer’s instructions. After washing, beads were resuspended in 20 μl Laemmli sample
buffer and heated to 70˚C for 10 minutes. Beads were removed by centrifugation and samples
were run on 4–12% Bis-Tris gels (Invitrogen). Transfer and western blotting was performed as
described above.
Enzyme-linked immunosorbent assays (ELISAs)
Secretion of HGF by 3T3-J2 cells following mitotic inactivation was assessed using a mouse
HGF DuoSet ELISA kit (R&D Systems; DY2207) performed according to the manufacturer’s
instructions. 3T3-J2 medium consisted of DMEM (Gibco) supplemented with 1X penicillin/
streptomycin (Gibco) and 9% bovine serum (Gibco). Cells were trypsinised and seeded in
fresh medium at feeder density following 2 hours of incubation with 0.4 μg/ml mitomycin C
(Sigma-Aldrich) and medium was collected for analysis and refreshed after 24 hours, 48 hours
and 72 hours.
Proliferation assays
To analyse EdU uptake, primary human airway epithelial cells were cultured in 3T3+Y until
approximately 70% confluence when they were washed with PBS and feeder cells were
removed by taking advantage of their greater trypsin sensitivity. After washing in DMEM con-
taining 10% FBS and then PBS, epithelial cells were treated with media as indicated for 12
hours. Cultures were treated with 10 μM EdU (Life Technologies Click-iT EdU Alexa Fluor
488) for the final 1 hour of the experiment. Single cell suspensions were obtained by trypsinisa-
tion, cells were stained according to the manufacturer’s instructions and then co-stained with
DAPI. Flow cytometry was performed using an LSRFortessa (BD Biosciences) and analysed
using FlowJo 10.0.6 (TreeStar).
For cell counting assays, primary human airway epithelial cells previously grown in 3T3+Y
were seeded in T25 flasks at a density of 5 x 105 cells in the following conditions: 3T3 co-cul-
ture in medium containing 5 μM Y-27632 and vehicle protein (3T3+Y+Vehicle), with medium
alone (i.e., no feeder cells; Y+Vehicle), or medium containing Y-2632 and either 3 ng/ml or 50
ng/ml hHGF. After 24, 48 and 72 hours, cells were trypsinised and counted. After 72 hours,
cells in a fourth condition were re-seeded in the same conditions in T25 flasks at a density of 5
x 105 cells per flask and counted after an additional 96 hours of culture.
For MTT assays, primary human airway epithelial cells previously grown in epithelial cell
culture medium without Y-27632 [DMEM/F12 in a 3:1 ratio, 1X penicillin–streptomycin, 10%
fetal bovine serum, 1% adenine, hydrocortisone (0.4 μg/ml), EGF (10 ng/ml), insulin (5 μg/
ml), 0.1 nM cholera toxin, 2 x 10−9 M T3 and gentamicin (10 μg/ml)] were seeded in 96-well
plates at a density of 5,000 cells/well for 24 hours without feeder cells or EGF. The following
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day, cells were treated in this medium with additional growth factors as indicated. Cells were
cultured for 10 days and one medium change was performed on day 5 of culture. At the given
end-points, adherent cells were stained with MTT dye solution (10 μl of 1:10 diluted MTT
stock solution in culture medium) for 3 hours at 37˚C. After incubation, the medium was
removed and 100 μl dimethyl sulfoxide (DMSO; Sigma-Aldrich) was added to dissolve the
MTT crystals. The eluted specific stain was measured using a spectrophotometer (560 nm).
Colony formation assays
For colony-forming assays in 3T3+Y, 1000 cultured airway epithelial cells previously grown in
3T3+Y were seeded per well of a 6-well plate containing inactivated 3T3-J2 feeder cells in epi-
thelial culture medium with Y-27632 and either a vehicle control or 100 nM PF-04217903, a
small molecule MET inhibitor. Cultures were maintained for 10 days and medium was
changed every other day. Colonies were stained using crystal violet (Sigma-Aldrich) at room
temperature for 20 minutes and washed repeatedly in water. Colonies of more than 10 cells
were counted manually using a light microscope.
For colony-forming assays in the absence of Y-27632, 1000 cultured airway epithelial cells
previously grown in epithelial cell culture medium without Y-27632 [DMEM/F12 in a 3:1
ratio, 1X penicillin–streptomycin, 10% fetal bovine serum, 1% adenine, hydrocortisone
(0.4 μg/ml), EGF (10 ng/ml), insulin (5 μg/ml), 0.1 nM cholera toxin, 2 x 10−9 M T3 and genta-
micin (10 μg/ml)] were seeded per well of a 6-well plate containing inactivated 3T3-J2 feeder
cells in the same medium without EGF. After 48 hours, medium was refreshed with medium
containing growth factors as indicated. Cultures were maintained for a further 8 days and
medium was changed on day 6 of culture. Colonies were stained using crystal violet (Sigma-
Aldrich) at room temperature for 20 minutes and washed repeatedly in water. Colonies of
more than 10 cells were counted manually using a light microscope.
Luciferase reporter assays
STAT6 consensus sequence reporter assays were performed by plating A431 cells in 96-well
plates at a density of 20,000 cells per well. After 48 hours, cells were co-transfected with STAT6
luciferase reporter (p4xSTAT6-Luc2P was a gift from Axel Nohturfft; Addgene plasmid
#35554) and renilla luciferase control (pGL4.74 [hRluc/TK]; Promega) plasmids using jetPEI
(Polyplus Transfection) according to the manufacturer’s instructions. 0.225 μg STAT6 reporter
and 0.025 μg renilla luciferase control were added to each well. After 24 hours, cells were
washed once with PBS and serum-starved in DMEM overnight. The following day, cells were
growth factor-stimulated in serum-free DMEM as indicated. To quantify the luciferase activ-
ity, a dual luciferase reporter kit (Promega) was used according to the manufacturer’s instruc-
tions. Assay reagents were injected and bioluminescence was recorded using a TROPIX
TR717 microplate luminometer (2 second delay, 10 second recording time).
Immunofluorescence
Cells were cultured in 8-well chamber slides (Ibidi) and fixed in 4% PFA for 20 minutes at
room temperature. Slides were washed with and stored in PBS until staining. Cells were per-
meabilised and blocked in PBS containing 10% FBS and 0.01% Triton X (block buffer) for 1
hour at room temperature. Primary antibodies–keratin 5 (KRT5; Abcam, ab17130), KRT14
(Covance, PRB-155P) and p63 (Abcam, ab53039)–were incubated overnight in block buffer
without Triton X at 4˚C. After three 5-minute PBS washes, species-appropriate secondary anti-
bodies (AlexaFluor dyes; Molecular Probes) were incubated at a 1:500 dilution in block buffer
without Triton X for 2 hours at room temperature. Cells were washed in PBS, counterstained
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using DAPI (1 μg/ml stock, 1:10,000 in PBS) and washed twice more in PBS. Images were
acquired using a Zeiss LSM700 confocal microscope.
Statistics
Statistical analysis was performed using GraphPad Prism as indicated in figure legends.
Results
Airway basal epithelial cell receptor tyrosine kinase activation by
3T3-J2-conditioned medium
Previous studies indicate that one or more secreted factors are responsible for the trophic
effects of 3T3-J2 murine embryonic fibroblast feeder cells on human epithelial cells [32]. To
investigate the nature of these signals, a receptor tyrosine kinase activation array [33] was per-
formed on primary human airway basal epithelial cells (KRT5+/p63+; S1 Fig) stimulated with
medium conditioned by 3T3-J2 fibroblasts (for a full list of phospho-receptor tyrosine kinases
in array, see S1 Table). Strong activation of the epidermal growth factor receptor (EGFR) and
the insulin-like growth factor 1 receptor (IGF1R) was observed in cells stimulated with both
base medium and conditioned medium, consistent with the inclusion of EGF and insulin in
the base medium (Fig 1A). Interestingly, the hepatocyte growth factor receptor (HGFR/MET)
was strongly phosphorylated at Y1234/Y1235 by conditioned medium but not by base medium
alone (Fig 1A). MET activation by 3T3-J2-conditioned medium was validated by western blot,
analysing three phosphorylation sites: tyrosine 1003 (Y1003), which leads to receptor ubiquiti-
nation and recycling via endosomal pathways [34], and Y1234/Y1235, which lies within the
activation loop of MET’s tyrosine kinase domain [35], were strongly phosphorylated, while
Y1349, an autophosphorylation site (Fig 1B) that generates a multisubstrate-docking site [36],
showed less marked phosphorylation (Fig 1C, S2 Fig and S3 Fig). Y-27632 alone was not suffi-
cient to induce MET phosphorylation (Fig 1A and 1C) and although apparently lower MET
phosphorylation in the presence of Y-27632 in the initial array (Fig 1A), this effect was not val-
idated in subsequent western blot analyses (Fig 1C, S2 Fig and S3 Fig).
Murine HGF activates intracellular signalling but does not affect basal cell
proliferation
Consistent with HGF-mediated crosstalk between fibroblast feeder cells and epithelial cells,
the amount of HGF secreted into culture medium by feeder cells increased over time following
mitotic inactivation (Fig 2A). However, previous work suggests that murine HGF (mHGF)
does not exert biological effects on human cells as a result of a failure to initiate autophosphor-
ylation of the multisubstrate-docking site [37]. Indeed, this site showed limited phosphoryla-
tion in airway basal cells in response to mHGF present in 3T3-J2-conditioned medium (Fig
1C, S2 Fig and S3 Fig). To investigate whether mHGF exerts biological effects on human air-
way basal cells, we examined their proliferation in response to 3T3-J2-conditioned medium.
Basal cell proliferation increased in response to 3T3-J2-conditioned medium compared with
epithelial growth medium alone as measured by EdU incorporation (Fig 2B). However, this
response was not MET-dependent as the small molecule MET inhibitor PF-04217903 [38] did
not reduce the amount of EdU incorporation following stimulation with 3T3+Y-conditioned
medium (Fig 2B). Similarly, the presence of PF-04217903 did not affect the colony-forming
efficiency of primary human airway epithelial cells (Fig 2C). Additional colony formation
assays using recombinant mHGF or recombinant human HGF (hHGF) showed that, although
mHGF supported the formation of some small colonies, hHGF allowed more colony
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formation and produced larger colonies (Fig 2D). To examine whether this was because hHGF
(but not mHGF) is mitogenic for airway basal cells, we performed MTT proliferation experi-
ments (Fig 2E), which confirmed that hHGF but not mHGF stimulated proliferation over a
10-day culture period. However, addition of hHGF to epithelial growth medium was not
Fig 1. Activation of the HGF receptor (MET) in primary human airway basal epithelial cells by 3T3-J2 murine embryonic fibroblast feeder cell-
conditioned medium. (A) Receptor tyrosine kinase array analysis of primary human airway basal cells stimulated for 30 minutes with 3T3-J2 feeder cell-
conditioned medium. Specific phosphorylation of the hepatocyte growth factor (HGF) receptor (HGFR/MET) at Y1234/Y1235 was observed in cells stimulated
with 3T3-J2-conditioned medium both in the presence and absence of Y-27632, a RHO-associated protein kinase (ROCK) inhibitor. The three duplicate spots in
the top left, top right and bottom left of each array are assay reference spots. This array was performed using one donor cell culture. (B) Schematic representation
of MET receptor structure showing relevant phosphorylation sites. Sema = semaphorin; PSI = plexins-semaphorins-integrins; IPT = immunoglobulins-plexins-
transcription factor. (C) Western blot confirmation in independent lysates of MET phosphorylation following stimulation of primary human airway basal
cells with 3T3-J2 feeder cell-conditioned medium for 30 minutes. Y indicates the presence of 5 μM Y-27632 in the culture medium. The blots shown are
representative of experiments performed on three donor cell cultures.
https://doi.org/10.1371/journal.pone.0197129.g001
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Fig 2. mHGF is secreted by 3T3-J2 fibroblasts following mitotic inactivation but primary human airway basal cell MET does not
mediate important aspects of co-culture expansion. (A) ELISA quantification of hepatocyte growth factor (HGF) secreted into culture
medium by 3T3-J2 feeder cells following mitotic inactivation with mitomycin C. Medium was collected and replaced with fresh medium after
24 and 48 hours (n = 4; mean +/- SEM;  indicates p<0.01 using a one-way ANOVA with Holm-Sidak’s correction for multiple
comparisons). (B) Flow cytometric analysis of EdU uptake in primary human airway basal cells treated with either epithelial culture medium
alone (+Y), 3T3-J2-conditioned epithelial growth medium (CM+Y) or the same medium containing 100 nM PF-0421903 (CM+Y+PF), a
small molecule MET inhibitor, for 12 hours (CM+Y+PF; n = 4 donor cultures performed in triplicate repeats; mean +/- SEM;  indicates
p<0.05 using a one-way ANOVA with Holm-Sidak’s correction for multiple comparisons). (C) Colony-forming efficiency of primary
human airway basal cells grown on 3T3-J2 feeder cells in the presence of 5 μM Y-27632 and either 100 nM PF-0421903 or a vehicle control
for 10 days (n = 5 donor cultures; ns indicates not significant using a paired t test; representative wells from one donor are shown in images).
(D) Colony-forming efficiency of primary human airway basal cells grown on 3T3-J2 feeder cells without EGF or Y-27632 for 10 days. 3 ng/
ml or 50 ng/ml mHGF or hHGF was added as indicated (n = 3 donor cultures;  represents p<0.05 and  represents p<0.01 using a using a
Incomplete MET activation in 3T3-J2 co-culture
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capable of replacing feeder cells as hHGF-treated cultures performed comparably to those in
basal culture medium alone (Fig 2F).
While proliferation of airway basal cells in 3T3-J2-conditioned medium was not MET-
dependent, investigation of the phosphorylation status of the MET downstream effector protein
GRB2-associated-binding protein 2 (GAB2) suggested that some intracellular MET signalling
events are initiated in response to mHGF (Fig 3A and S2 Fig). A previous study demonstrated
that GAB2 positively influences interleukin-13 (IL-13)-dependent STAT6 phosphorylation at
tyrosine 641 (Y641) in differentiated airway goblet cells [39, 40]. As such, the phosphorylation
status of STAT6 in response to stimulation with 3T3-J2-conditioned medium was determined.
STAT6 was robustly phosphorylated in epithelial cells treated with 3T3-J2-conditioned medium
in both the absence and the presence of Y-27632, while low levels of STAT6 phosphorylation
were observed in cells treated with base epithelial growth medium only (Fig 3A and S2 Fig).
STAT6 phosphorylation was MET-dependent as it was prevented by treatment with PF-
04217903 (Fig 3A and S2 Fig).
Human HGF phosphorylates STAT6 in human airway basal cells
The phosphorylation events described above could be explained by the presence of co-factors
in 3T3-J2-conditioned medium or by the non-physiological action of mHGF on the human
MET receptor. To address this, we investigated MET, GAB2 and STAT6 phosphorylation lev-
els following stimulation of airway basal cells with either recombinant mHGF or recombinant
hHGF. In the catalytic domain (Y1234/1235), MET was phosphorylated in a dose-dependent
manner in response to HGF of both species (Fig 3B and S3 Fig), while the autophosphorylated
multisubstrate-docking domain of MET (Y1349), which was inefficiently activated by mHGF
in 3T3-J2-conditioned medium, was only activated in response to very high concentrations of
mHGF (Fig 3B and S3 Fig). Dose-response experiments revealed that hHGF treatment led to
STAT6 phosphorylation in a dose-dependent manner (Fig 3C and S4 Fig). The timecourse of
MET, GAB2 and STAT6 phosphorylation in response to hHGF was also comparable (S4 Fig).
Although cooperation between IL-4/IL-13-driven STAT6 activation and MET signalling
has previously been shown in myeloid cells [41], the phosphorylation of STAT6 in response to
HGF has not been described so we examined STAT6 activation in this context. As GAB2 influ-
ences IL-13-induced STAT6 phosphorylation [39], we investigated whether a MET-GAB2--
STAT6 pathway is activated in airway basal cells in response to HGF. However, knockdown of
GAB2 using siRNA did not affect STAT6 phosphorylation (Fig 4A and S5 Fig), suggesting that
HGF-induced phosphorylation of STAT6 is not dependent on GAB2.
In further mechanistic studies, we examined whether HGF-induced STAT6 phosphoryla-
tion in epithelial cancer cell lines. HGF treatment increased STAT6 Y641 phosphorylation in
both A549 (lung adenocarcinoma) and A431 (epidermoid) cancer cell lines following stimula-
tion with hHGF (Fig 4B and S6 Fig). In contrast, no upregulation of STAT6 phosphorylation
was detected in HGF-treated primary human lung fibroblasts (Fig 4B and S6 Fig), consistent
two-way ANOVA with Holm-Sidak’s correction for multiple comparisons to compare each concentration of HGF to the vehicle control
group; representative wells from one donor are shown in images). (E) MTT assay using primary human airway epithelial cells cultured in
medium without EGF or Y-27632 for 10 days. 3 or 50 ng/ml mHGF or hHGF was added as indicated (n = 3 donor cultures;  represents
p<0.01 and  represents p<0.001 using a using a two-way ANOVA with Holm-Sidak’s correction for multiple comparisons to compare
each concentration of HGF to the vehicle control group). (F) Cell counts comparing primary human airway basal cell number in 3T3-J2 co-
culture in medium containing Y-27632 and vehicle protein (3T3+Y+Vehicle) with medium alone (i.e. no feeder cells; Y+Vehicle) and
medium plus either 3 ng/ml or 50 ng/ml hHGF. Cells were analysed after 24, 48 or 72 hours. In an additional condition, after 72 hours cells
were passaged to the same density as at time 0 and analysed after a further 96 hours (n = 3 donor cultures performed in triplicate repeats;
mean +/- SEM;  indicates p<0.0001 using a two-way ANOVA with Holm-Sidak’s correction for multiple comparisons to compare media
compositions with the 3T3+Y group).
https://doi.org/10.1371/journal.pone.0197129.g002
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with the absence of MET receptor expression in these cells [42]. As STAT3 binds directly to
the MET receptor via its SH2 domain [43, 44] and STAT6 also contains an SH2 domain [45],
co-immunoprecipitation experiments were performed to determine whether STAT6 binds to
MET following stimulation with hHGF. In immunoprecipitation assays using A431 cells, we
did not detect STAT6 bound to MET, while receptor-bound STAT3 was detected (Fig 4C and
S6 Fig). This finding suggests that hHGF stimulation does not lead to the direct association of
STAT6 with MET and that unknown intermediate kinases are responsible for STAT6
Fig 3. 3T3-J2-conditioned medium and hHGF stimulate MET, GAB2 and STAT6 phosphorylation in primary human airway basal
cells. (A) Western blot analysis of MET, GRB2-associated-binding protein 2 (GAB2) and signal transducer and activator of transcription 6
(STAT6) phosphorylation status following stimulation of primary human airway basal cells with basal or 3T3-J2-conditioned medium (CM)
for 30 minutes. Y indicates the presence of 5 μM Y-27632 and PF indicates 100 nM PF-04217903. Blots are from one donor cell culture and
are representative of experiments performed in three further donor cultures. (B) Western blot analysis of MET, GAB2 and STAT6
phosphorylation status in primary human airway basal cells stimulated with either 3 ng/ml or 50 ng/ml recombinant mouse (mHGF) or
recombinant human hepatocyte growth factor (hHGF) for 30 minutes. Blots are from one donor cell culture and are representative of
experiments performed in two further donor cultures. (C) Dose-response western blot analysis of HGF-induced STAT6 phosphorylation in
primary human airway basal cells stimulated with the indicated amount of hHGF for 30 minutes. This result was replicated in a second
donor cell culture.
https://doi.org/10.1371/journal.pone.0197129.g003
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Fig 4. HGF-induced STAT6 phosphorylation in primary human airway basal cells occurs independently of GAB2 activity and MET
receptor binding and does not result in STAT6 nuclear translocation or transcriptional activity. (A) Western blot analysis of STAT6 Y641
phosphorylation levels in human airway basal cells treated with either 5 nM non-silencing siRNA or 5 nM anti-GAB2 siRNA. Cells treated
with a 0.1% bovine serum albumin (BSA) vehicle control were compared with matched cells stimulated with either 3 ng/ml or 50 ng/ml
recombinant human hepatocyte growth factor (hHGF) for 30 minutes. (B) Western blot analysis of STAT6 phosphorylation in the A549
cancer cell line, the A431 cancer cell line and primary human lung fibroblasts following stimulation with either a BSA control or 50 ng/ml
hHGF for 30 minutes. This blot is representative of two independent experiments. (C) Western blot analysis of co-immunoprecipitation
experiment. Unstimulated A431 cancer cells were compared with matched cells stimulated with 3 or 50 ng/ml hHGF for 30 minutes. MET
was immunoprecipitated using Dynabeads and the supernatant retained. STAT6 was not co-immunoprecipitated with MET but was found in
the unbound protein fraction. STAT3 binding to MET was used as a positive control. These blots are representative of two experiments in
A431 cells and a further experiment in primary human airway basal cells that did not detect HGF-STAT6 binding. (D) Quantification of
firefly luciferase STAT6 reporter activity using luminescence in A431 cancer cells treated for 30 minutes, 1 hour or 2 hours with either a
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phosphorylation in response to MET activation; however, a limitation of these experiments is
that we might not have detected transient or low abundance STAT6-MET interactions.
The HGF-induced STAT6 complex is not transcriptionally active
To investigate whether HGF induces a STAT6-dependent transcriptional response, we used a
STAT6 consensus sequence luciferase reporter assay. A431 cells were transfected with a
p4xSTAT6-Luc2P STAT6 luciferase reporter plasmid that contains four tandem repeats of
STAT6/cEBP-binding sites (TTCN4GAA) from the human germline ε promoter sequence
upstream of the luciferase gene. Cells were incubated with either a vehicle control, 3 ng/ml
hHGF, 50 ng/ml hHGF, 3 ng/ml recombinant human IL-13 (hIL-13) or 50 ng/ml hIL-13,
which was used as a positive control because IL-13 is known to activate STAT6-dependent
transcription in epithelial cells [46, 47]. After 2 hours, hIL-13-stimulated cells showed strong
expression of luciferase, indicating active STAT6 transcription, while stimulation with hHGF
had no effect on luciferase expression (Fig 4D), suggesting that HGF does not activate STAT6--
dependent transcription.
The lack of HGF-induced, STAT6-dependent transcriptional activity in these experiments
appeared to contradict our earlier findings showing that STAT6 is robustly phosphorylated at
Y641, a site whose phosphorylation is associated with STAT6 dimerisation and translocation
into the nucleus [40]. To investigate the basis of this, we used subcellular fractionation to reveal
the localisation of STAT6 following stimulation with either hHGF or hIL-13. After 2 hours,
phosphorylated STAT6 was found in the nucleus of cells stimulated with IL-13 but remained
in the cytoplasm of cells stimulated with hHGF (Fig 4E and S7 Fig), explaining the lack of
STAT6 transcriptional response following stimulation with HGF.
Discussion
3T3-J2 mouse embryonic feeder cells are supportive of human epithelial cell expansion in vitro
[48] and soluble factors appear to mediate their effect(s) [32]. Data from our laboratory also
indicated that secreted factors mediate the effect of 3T3-J2 co-culture but that they might be
required in constant supply: conditioned medium is insufficient to fully recapitulate the effects
of co-culture [49]. To address the contribution of growth factor signalling in 3T3-J2 fibroblast
co-cultures with primary human airway basal cells, we used a receptor tyrosine kinase array to
identify candidate pathways. Given the complex composition of feeder cell-conditioned
medium, we anticipated that we would uncover a range of candidates but in fact only the HGF
receptor, MET, was phosphorylated in airway basal cells following stimulation with 3T3-J2
fibroblast-conditioned medium. A limitation of the strategy employed here is that conditioned
medium was collected from epithelial cell-naïve fibroblast feeder cells and it is possible that
epithelial cell-derived signals modulate the feeder cell secretome in co-culture [50].
Nevertheless, HGF-MET signalling emerged as a promising candidate mediating feeder
cell-epithelial cell cross-talk as it was secreted by feeder cells in increasing amounts following
mitotic inactivation and partially activated MET on human epithelial cells. This is consistent
with the physiological role of HGF-MET signalling, where mesenchyme-derived HGF signals
vehicle control, 50 ng/ml hHGF or 50 ng/ml recombinant human interleukin-13 (hIL-13). Values were normalised according to expression
from a constitutively active renilla luciferase plasmid. No HGF-induced STAT6 activity was seen in three independent experiments. (E)
Western blot analysis of STAT6 Y641 phosphorylation status in A431 cancer cells treated with 50 ng/ml hHGF or 50 ng/ml hIL-13 for 30
minutes. Whole cell lysates were obtained using RIPA buffer and compared with independent lysates prepared using a subcellular
fractionation kit. These blots are representative of two independent experiments using A431 cells and two further experiments using primary
human airway basal cells.
https://doi.org/10.1371/journal.pone.0197129.g004
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to MET on epithelial cells to initiate diverse responses such as proliferation, migration, survival
and differentiation [51]. The identification of MET activation in human epithelial cells stimu-
lated with 3T3-J2-conditioned medium was particularly interesting as murine HGF is not
thought to bind efficiently to the human MET receptor [52]. Indeed, autophosphorylation of
the MET receptor multisubstrate-docking site was lower in response to mHGF in 3T3-J2-con-
ditioned medium compared with hHGF. Since neither proliferation induced by 3T3-J2-condi-
tioned medium nor colony formation was affected by MET inhibition and recombinant HGF
could not replace the requirement for feeder cells, we conclude that HGF signalling is not
responsible for the improvements in epithelial cell culture conditions conferred by 3T3 co-
culture.
Despite this, characterisation of signalling downstream of MET in response to 3T3-J2-con-
ditioned medium identified MET-dependent phosphorylation of GAB2 and the transcription
factor STAT6, a novel target of MET signalling, and these findings were validated using recom-
binant hHGF. STAT6-mediated signalling occurs in response to IL-4 and IL-13, cytokines that
are implicated in the pathogenesis of airway diseases [40, 53, 54]. IL-13 treatment of an epithe-
lial cancer cell line demonstrated STAT6 activation and translocation to the nucleus. Although,
HGF treatment significantly increased STAT6 activation as determined by the levels of STAT6
phosphorylation, HGF-induced phosphorylated STAT6 did not activate transcriptional targets
as it did not translocate to the nucleus.
One possible explanation is that further post-translational modifications to STAT6, in addi-
tion to Y641 phosphorylation, are required to allow dimerisation and/or nuclear translocation.
Alternatively, a cytoplasmic inhibitory mechanism may prevent these; a previous study showed
that cytoplasmic phosphorylated STAT6 cannot bind to DNA in vitro but that detergent treat-
ment confers on it DNA-binding ability [55]. Although the identity of this inhibitor and the
mechanism of inhibition are unknown, one possibility is that a bound factor both prevents the
nuclear import of STAT6 and masks the DNA-binding site. Importin-α5 binds competitively
to the STAT1 DNA-binding site [56], giving biological precedent to this hypothesis.
Overall, our results suggest that mHGF cannot be considered completely inactive on
human cells. Although the characteristic proliferative and migratory effects of HGF are lacking
following stimulation with mHGF due to inefficient multisubstrate-docking site phosphoryla-
tion [37], some intracellular signalling–including the phosphorylation of GAB2 and STAT6 –
proceeds. It is likely that the behavior of other cytoplasmic proteins and transcription factors
are modified by the incomplete activation of MET by mHGF. While more research is clearly
required to understand the factors that enable 3T3-J2-mediated epithelial cell expansion and
stem cell retention, these findings draw attention to the possible relevance of complex cross-
species protein interactions in this system.
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S1 Table. Receptor tyrosine kinases assayed in the R&D systems human phospho-receptor
tyrosine kinase (RTK) array kit (Catalogue Number ARY001B).
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S1 Fig. Immunofluorescence demonstrates expression of basal epithelial cell markers p63,
keratin 5 (KRT5) and keratin 14 (KRT14) in both BEGM and 3T3+Y cell culture condi-
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S2 Fig. Western blot analyses of MET, GAB2 and STAT6 phosphorylation status in pri-
mary human airway basal epithelial cells treated with 3T3-J2 conditioned medium. Y
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indicates the presence of 5 μM Y-27632; PF indicates 100 nM PF-04217903. This figure is asso-
ciated with Figs 1C and 3A. Each group of blots (A, B and C) are biological replicates from
independent donor cultures.
(TIFF)
S3 Fig. Western blot analyses of MET, GAB2 and STAT6 phosphorylation status in pri-
mary human airway basal epithelial cells treated with recombinant murine and human
HGF. Y indicates the presence of 5 μM Y-27632; PF indicates 100 nM PF-04217903. This fig-
ure is associated with Fig 3B and each group of blots (A, B, C and D) are from independent
donor cultures.
(TIFF)
S4 Fig. Additional western blot analyses of MET, GAB2 and STAT6 phosphorylation sta-
tus in primary human airway basal epithelial cells treated with recombinant human HGF.
(A) Western blot analysis of the phosphorylation status of STAT6 following treatment with a
dose range of recombinant human HGF. This panel is associated with Fig 3C and was per-
formed on an independent donor culture. (B) Timecourse of MET, GAB2 and STAT6 phos-
phorylation status in primary human airway epithelial cells in response to 50 ng/ml
recombinant human HGF.
(TIFF)
S5 Fig. Western blot analyses of STAT6 phosphorylation status in primary human airway
basal epithelial cells treated with recombinant human HGF in the presence of anti-GAB2
siRNA. This figure is associated with Fig 4A and each group of blots (A and B) were performed
on independent donor cultures.
(TIFF)
S6 Fig. Additional western blot analyses of HGF-induced STAT6 phosphorylation in A431
cells. (A) This panel is associated with Fig 4B and was performed on independent cell lysates.
(B) This panel is associated with Fig 4C and was performed on independent A431 cell lysates
but using a lower (1 mg) protein input. (C) This panel is associated with Fig 4C and was per-
formed on a primary human airway basal cell culture.
(TIFF)
S7 Fig. Analysis of STAT6 cellular localisation by subcellular fractionation. This figure is
associated with Fig 4E. (A) Subcellular fractionation confirmation for the experiment pre-
sented in Fig 4E using A431 cell lysates. (B) Replication of the experiment shown in Fig 4E in
independent A431 cell lysates using 50 ng/ml hHGF and 50 ng/ml hIL-13. (C, D) Replication
of our findings in A431 cancer cells in two independent primary human airway basal cell cul-
tures using 50 ng/ml hHGF and 50 ng/ml hIL-13.
(TIFF)
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